How OMT Benefits Newly Diagnosed Patients With Respiratory Illness When Given Alongside Other Standard Care.

Part of paid clinical trials in Bloomsburg, Pennsylvania.

Sponsor
Geisinger Clinic
Study ID
NCT06495021
Status
Recruiting
Apply to this trial

Conditions

  • Bronchitis
  • Pneumonia
  • Respiratory Disease
  • Respiratory Tract Infections
  • Sinusitis

Eligibility Criteria

Sex
ALL
Age
65 Years - 100 Years
Healthy Volunteers
Not accepted

Interventions

  • Lymphatic Pump Osteopathic Manipulative Therapy — PROCEDURE
    OMT is a series of manual pressure and physical stimulation among various parts of the body to stimulate fluid movement and immune response in patients with various symptoms and disease. This may help with conditions such as edema, clearance of infections, facilitate healing and circulation, and bolster the immune response. Specifically, the lymphatic pump type of OMT targets the head, neck, thoracic region, lumbar and sacral regions, pelvis, arms, legs, and abdomen.

Study Details

This study is to see Osteopathic Manipulative Therapy, or OMT, can aid in treating patients being seen for respiratory illness and associated symptoms. The hypothesis is that the addition of OMT therapy, alongside other standard care (such as a medication), can help lessen patient symptoms sooner than just other treatment alone, and the duration of the condition will shorten as well.

Key Dates

Start date
Dec 31, 2024
Status verified
Jul 2025
Primary completion
Jun 30, 2026
Completion
Jun 30, 2026

Study Design

Enrollment
68 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • No Intervention: Control
    Patients in the control group will receive normal standard care, including any prescriptions, follow-up instructions, etc., as given by the provider to help treat their condition.
  • Experimental: Treatment
    Patients will receive lymphatic pump OMT therapy in addition to other standard care (similar to the control patients, this would be a medication, follow-up instructions, etc.)

Primary Outcome Measure

To address the magnitude in which lymphatic pump OMT improves respiratory illness symptom severity and overall sickness duration when combined with standard care treatment. [ Time Frame: Through study completion of up to one year. ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Geisinger 65-Forward, BuckhornBloomsburgPennsylvania17815
Margaret Moore, DO
[email protected]
570-416-5435
Margaret Moore, DO (PRINCIPAL_INVESTIGATOR)

Find similar trials in Bloomsburg, PA

By research site
Geisinger 65-Forward, Buckhorn· Bloomsburg, PA

Related Studies